Showing 1 - 1 results of 1 for search 'Jeffery Kutok', query time: 0.02s Refine Results
  1. 1
    The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies.

    The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies. by Kerrie Faia, Kerry White, Erin Murphy, Jennifer Proctor, Melissa Pink, Nicole Kosmider, Karen McGovern, Jeffery Kutok

    Published 2018-01-01
    Get full text
    Article

Search Tools: